
I'm reiterating Okta as a buy, with a new $182 price target, following strong Q2 2027 results and early AI-agent commercialization evidence. OKTA delivered 11% revenue growth, 28%+ non-GAAP operating and FCF margins, and improved net retention to 107%, maintaining robust Rule of 40 performance. AI-agent deals are gaining traction but remain immaterial to 2027 results; their impact is expected to become material from 2028 onward if adoption continues.










